Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

Volumn 14, Issue 2, 2000, Pages 146-150

  Spangler, Elizabeth A ^a   Rogers, Kenita S ^a   Thomas, Jennifer S ^a   Pustejovsky, Denise ^a   Boyd, Stephanie L ^a   Shippen, Dorothy E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ASCITES FLUID; CAT; CAT DISEASE; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; ENZYMOLOGY; METABOLISM; NEOPLASM; PLEURA EFFUSION; SENSITIVITY AND SPECIFICITY;

ANIMALS; ASCITIC FLUID; CAT DISEASES; CATS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; SENSITIVITY AND SPECIFICITY; TELOMERASE;

EID: 0034150545     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2000.tb02228.x     Document Type: Article

References (30)

1. 1 Collins K. Structure and function of telomerase. Curr Opin Cell Biol 1996 ; 8: 374–380.
2. 2 Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 ; 266: 2011–2015.
3. 3 Bacchetti S. Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev Biol 1996 ; 7: 21–39.
4. 4 Holt SE, Shay JW, Wright WE. Refining the telomere‐telomerase hypothesis of aging and cancer. Nat Biotechnol 1996 ; 14: 836–839.
5. 5 Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998 ; 95: 90–92.
6. 6 Bacchetti S, Counter CM. Telomeres and telomerase in human cancer (review). Int J Oncol 1995 ; 7: 423–432.
7. 7 Biller BJ, Kitchell BE, Cadile CD. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am J Vet Res 1998 ; 59: 1526–1529.
8. 8 Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP‐eze telomerase detection kit. Methods Cell Sci 1996 ; 18: 237–248.
9. 9 Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994 ; 91: 2900–2904.
10. 10 Duggan BD, Wan M, Yu MC, et al. Detection of ovarian cancer cells: Comparison of a telomerase assay and cytologic examination. J Natl Cancer Inst 1998 ; 90: 238–242.
11. 11 Cunningham VJ, Markham N, Shroyer AL, Shroyer KR. Detection of telomerase expression in fine‐needle aspirations and fluids. Diagn Cytopathol 1998 ; 18: 431–436.
12. 12 Toshima S, Arai T, Yasuda Y, et al. Cytological diagnosis and telomerase activity of cells in effusions of body cavities. Oncol Rep 1999 ; 6: 199–203.
13. 13 Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: Diagnostic significance. J Clin Oncol 1998 ; 16: 567–573.
14. 14 Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997 ; 79: 362–369.
15. 15 Kinoshita H, Ogawa O, Kakehi Y, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997 ; 89: 724–730.
16. 16 O'Brien PJ, Lumsden JH. The cytologic examination of body cavity fluids. Semin Vet Med Surg 1988 ; 3: 140–156.
17. 17 Birchard SJ, Smeak DD, McLoughlin MA. Treatment of idio‐pathic chylothorax in dogs and cats. J Am Vet Med Assoc 1998 ; 212: 652–657.
18. 18 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding. Anal Biochem 1976 ; 72: 248–254.
19. 19 Davies C, Forrester SD. Pleural effusion in cats: 82 cases (1987 to 1995). J Small Anim Pract 1996 ; 37: 217–224.
20. 20 Sisson D, Thomas WP, Ruehl WW, Zinkl JG. Diagnostic value of pericardial fluid analysis in the dog. J Am Vet Med Assoc 1984 ; 184: 51–55.
21. 21 Edwards NJ. The diagnostic value of pericardial fluid pH determination. J Am Anim Hosp Assoc 1996 ; 32: 63–67.
22. 22 Light RW, MacGregor MI, Ball WC, Luchsinger PC. Diagnostic significance of pleural fluid pH and PCO 2. Chest 1973 ; 64: 591–596.
23. 23 Kindig JR, Goodman MR. Clinical utility of pericardial fluid pH determination. Am J Med 1983 ; 75: 1077–1079.
24. 24 Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995 ; 155: 3711–3715.
25. 25 Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996 ; 219: 649–655.
26. 26 Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996 ; 183: 2471–2479.
27. 27 Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase in normal B lymphocytes and non‐Hodgkin's lymphomas. Blood 1996 ; 88: 222–229.
28. 28 Bryan TM, Englezou A, Dalla‐Pozza L, et al. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor‐derived cell lines. Nat Med 1997 ; 3: 1271–1274.
29. 29 Bryan TM, Englezou A, Gupta J, et al. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995 ; 14: 4240–4248.
30. 30 Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997 ; 91: 25–34.